Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Biological characterization of ovarian cancer: prognostic and therapeutic implications.

× No keyword cloud information.

13 in total

1. miR-133a suppresses ovarian cancer cell proliferation by directly targeting insulin-like growth factor 1 receptor.

Authors: Jinling Guo; Bairong Xia; Fanling Meng; Ge Lou
Journal: Tumour Biol Date: 2013-10-15

2. Upregulation of microRNA-18b induces phosphatase and tensin homolog to accelerate the migration and invasion abilities of ovarian cancer.

Authors: Xiaofang Han; Yan Zhang; Dong Wang; Xinyun Fu; Meiqing Li; Aiming Wang
Journal: Oncol Lett Date: 2017-08-31 Impact factor: 2.967

3. miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1.

Authors: Fanfei Kong; Chaoyang Sun; Zhongxian Wang; Lingfei Han; Danhui Weng; Yunping Lu; Gang Chen
Journal: J Huazhong Univ Sci Technolog Med Sci Date: 2011-08-07

4. MiR-106a targets Mcl-1 to suppress cisplatin resistance of ovarian cancer A2780 cells.

Authors: Yu-Mei Rao; Hui-Rong Shi; Mei Ji; Cai-Hong Chen
Journal: J Huazhong Univ Sci Technolog Med Sci Date: 2013-08-01

5. Targeting cleavage and polyadenylation specific factor 1 via shRNA inhibits cell proliferation in human ovarian cancer.

Authors: Beiguang Zhang; Ying Liu; Donghui Liu; Lei Yang
Journal: J Biosci Date: 2017-09 Impact factor: 1.826

Review 6. Role of long non-coding RNA in tumor drug resistance.

Authors: Heng Deng; Jun Zhang; JinJun Shi; ZhengDong Guo; ChunRong He; Li Ding; Jin Hai Tang; Yong Hou
Journal: Tumour Biol Date: 2016-07-05

7. miR-494 suppresses tumor growth of epithelial ovarian carcinoma by targeting IGF1R.

Authors: Na Li; Xiaosu Zhao; Lufei Wang; Shi Zhang; Manhua Cui; Jin He
Journal: Tumour Biol Date: 2015-12-22

8. Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation.

Authors: T G P Grunewald; U Kammerer; C Winkler; D Schindler; A Sickmann; A Honig; E Butt
Journal: Br J Cancer Date: 2007-01-09 Impact factor: 7.640

9. Prognostic significance of pretreatment VEGF, survivin, and Smac/DIABLO serum levels in patients with serous ovarian carcinoma.

Authors: Bozena Dobrzycka; Beata Mackowiak-Matejczyk; Katarzyna Maria Terlikowska; Bozena Kulesza-Bronczyk; Maciej Kinalski; Slawomir Jerzy Terlikowski
Journal: Tumour Biol Date: 2015-01-12

10. MicroRNA-mRNA functional pairs for cisplatin resistance in ovarian cancer cells.

Authors: Mei Liu; Xin Zhang; Chen-Fei Hu; Qing Xu; Hong-Xia Zhu; Ning-Zhi Xu
Journal: Chin J Cancer Date: 2014-02-28